Health workers’ perceptions and challenges in implementing meningococcal serogroup a conjugate vaccine in the routine childhood immunization schedule in Burkina Faso

BACKGROUND: Meningococcal serogroup A conjugate vaccine (MACV) was introduced in 2017 into the routine childhood immunization schedule (at 15–18 months of age) in Burkina Faso to help reduce meningococcal meningitis burden. MACV was scheduled to be co-administered with the second dose of measles-con...

Descripción completa

Detalles Bibliográficos
Autores principales: Nkwenkeu, Sylvain F., Jalloh, Mohamed F., Walldorf, Jenny A., Zoma, Robert L., Tarbangdo, Felix, Fall, Soukeynatou, Hien, Sansan, Combassere, Roland, Ky, Cesaire, Kambou, Ludovic, Diallo, Alpha Oumar, Krishnaswamy, Akshaya, Aké, Flavien H., Hatcher, Cynthia, Patel, Jaymin C., Medah, Isaïe, Novak, Ryan T., Hyde, Terri B., Soeters, Heidi M., Mirza, Imran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7031928/
https://www.ncbi.nlm.nih.gov/pubmed/32075630
http://dx.doi.org/10.1186/s12889-020-8347-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7031928/
https://www.ncbi.nlm.nih.gov/pubmed/32075630
http://dx.doi.org/10.1186/s12889-020-8347-z

Ejemplares similares